Single-Agent Divarasib in Patients With <i>KRAS G12C</i>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.

Sacher AG, Miller WH, Patel MR, Paz-Ares L, Santoro A, Ahn MJ, Dziadziuszko R, Freres P, Luo J, Bowyer S, Desai J, Markman B, De Miguel M, Deva S, Falcon A, Alonso G, Guedes JD, Kim SH, Krebs MG, Laurie SA, Massarelli E, Medina L, Prenen H, Amatu A, Van Dongen M, Choi Y, Hou X, Qi T, Lin MT, Koli K, Mayo MC, Yau KK, Royer-Joo S, Chang J, Jun T, Dharia NV, Schutzman JL, Lorusso P, GO42144 Investigator Study group, GO42144 Investigator Study Group.

Open source

DOI
10.1200/jco-25-00040
Published
2025-07-09
Container
J Clin Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-00040,
  title = {Single-Agent Divarasib in Patients With \<i\>KRAS G12C\</i\>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.},
  author = {Sacher AG and  Miller WH and  Patel MR and  Paz-Ares L and  Santoro A and  Ahn MJ and  Dziadziuszko R and  Freres P and  Luo J and  Bowyer S and  Desai J and  Markman B and  De Miguel M and  Deva S and  Falcon A and  Alonso G and  Guedes JD and  Kim SH and  Krebs MG and  Laurie SA and  Massarelli E and  Medina L and  Prenen H and  Amatu A and  Van Dongen M and  Choi Y and  Hou X and  Qi T and  Lin MT and  Koli K and  Mayo MC and  Yau KK and  Royer-Joo S and  Chang J and  Jun T and  Dharia NV and  Schutzman JL and  Lorusso P and  GO42144 Investigator Study group and  GO42144 Investigator Study Group.},
  year = {2025},
  journal = {J Clin Oncol},
  doi = {10.1200/jco-25-00040},
  url = {https://doi.org/10.1200/jco-25-00040}
}

RIS

TY  - JOUR
TI  - Single-Agent Divarasib in Patients With <i>KRAS G12C</i>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.
AU  - Sacher AG
AU  -  Miller WH
AU  -  Patel MR
AU  -  Paz-Ares L
AU  -  Santoro A
AU  -  Ahn MJ
AU  -  Dziadziuszko R
AU  -  Freres P
AU  -  Luo J
AU  -  Bowyer S
AU  -  Desai J
AU  -  Markman B
AU  -  De Miguel M
AU  -  Deva S
AU  -  Falcon A
AU  -  Alonso G
AU  -  Guedes JD
AU  -  Kim SH
AU  -  Krebs MG
AU  -  Laurie SA
AU  -  Massarelli E
AU  -  Medina L
AU  -  Prenen H
AU  -  Amatu A
AU  -  Van Dongen M
AU  -  Choi Y
AU  -  Hou X
AU  -  Qi T
AU  -  Lin MT
AU  -  Koli K
AU  -  Mayo MC
AU  -  Yau KK
AU  -  Royer-Joo S
AU  -  Chang J
AU  -  Jun T
AU  -  Dharia NV
AU  -  Schutzman JL
AU  -  Lorusso P
AU  -  GO42144 Investigator Study group
AU  -  GO42144 Investigator Study Group.
PY  - 2025
JO  - J Clin Oncol
DO  - 10.1200/jco-25-00040
UR  - https://doi.org/10.1200/jco-25-00040
ER  -

APA

AG, S., WH, M., MR, P., L, P., A, S., MJ, A., R, D., P, F., J, L., S, B., J, D., B, M., M, D. M., S, D., A, F., G, A., JD, G., SH, K., MG, K., SA, L., E, M., L, M., H, P., A, A., M, V. D., Y, C., X, H., T, Q., MT, L., K, K., MC, M., KK, Y., S, R., J, C., T, J., NV, D., JL, S., P, L., group, G. I. S., & Group., G. I. S. (2025). Single-Agent Divarasib in Patients With <i>KRAS G12C</i>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.. J Clin Oncol. https://doi.org/10.1200/jco-25-00040

Source records